Category Archives: DBDS

DBDS researchers Ruishan Liu (first author, pictured here), Ying Lu, James Zou and colleagues have been named recipients of a 2022 Top Ten Clinical Research Achievement Award, for their Nature publication entitled “Evaluating eligibility criteria of oncology trials using real-world data and AI.” The research study will be honored at an awards gala, to be held at the Hyatt Regency McCormick Place in Chicago on April 19, 2022. These awards identify and celebrate major advances in the biomedical field resulting from the nation’s investment in health and welfare.

Access the Clinical Research press release

Ying Lu [pictured here], together with visiting scholar Ruben van Eijk and Tze Lai and Lu Tian of the Department of Biomedical Data Science and the Center for Innovative Study Design, plus Lorene Nelson of Epidemiology and the Center for Population Health Sciences, have recently won an award from UC Berkeley-Stanford Industrial Relations & Digital Health Research Project Solicitations on their proposed project, “Integrating Real World Evidence from Concurrent Registries into ALS Clinical Trials.” This award paves the way for software development and training for industry users.

Read more about the UCB and Stanford Digital Health Research Collaborative

DBDS faculty researcher Teri Klein is one of “Nine researchers from Stanford University and the SLAC National Accelerator Laboratory [who] have been named Fellows of the American Association for the Advancement of Science (AAAS). AAAS describes their Fellows as ‘a distinguished cadre of scientists, engineers and innovators who have been recognized for their achievements across disciplines ranging from research, teaching and technology, to administration in academia, industry and government, to excellence in communicating and interpreting science to the public.'” Dr Klein is being recognized for her work in the “development, implementation and leadership of the PharmGKB resource, a database providing information about how human genetic variation affects response to medications.”

Access the Stanford Report

DBDS faculty researchers Aaron Newman, Serena Yeung, and James Zou have been selected to join the second cohort of scientists to be named Chan Zuckerberg Biohub Investigators following a competition for individual awards. (The first competition for individual awards was held in 2016, for awards beginning 2017, and a competition for team-based awards was held in 2018.) The Chan Zuckerberg Biohub Investigator Program, open to faculty from Stanford University, UC San Francisco, and UC Berkeley, funds innovative, visionary research with the goal of building and sustaining an engaged, interactive, and collaborative community of researchers that spans across disciplines and across the three campuses to help solve critical challenges in biomedicine.

Read the press release

Access Stanford announcement